Exosomal TFF3 promotes colorectal cancer progression via the LINC00941 pathway

Background: Colorectal cancer (CRC) is among the most prevalent malignancies globally, characterized by high mortality rate, and a significant reduction in patients’ quality of life. Tumor-derived exosomes act as key mediators of interactions between the cells, and transmit oncogenic signals to nearby or distant cells and promote cancer progression. Trefoil factor 3 (TFF3) has vital function in metastasis, tumor growth, and oncogenic transformation in multiple carcinomas. Nevertheless, regulatory function of exosomal TFF3 and molecular mechanistic processes behind its function in CRC progression are not well understood. Methods: The exosomes were characterized using transmission electron microscopy. Protein expression levels were determined by western blotting. Exosome uptake was assessed using PKH-26 fluorescence in immunofluorescence assays. The colony formation and Cell Counting Kit-8 (CCK-8) assays were used to measure cell proliferation, while Transwell and wound healing assays to evaluate cell invasion and migration abilities. LINC00941 expression was quantified by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Tumor growth was assessed in vivo assay, and Ki67 expression was examined through immunohistochemistry (IHC) assay. Results: This work revealed TFF3 being overexpressed in CRC-derived exosomes. Exosomal TFF3 substantially increased CRC cell invasion, migration, and proliferation. Mechanistically, exosomal TFF3 upregulated LINC00941 expression, thereby accelerating CRC progression. The exosomal TFF3 enhanced tumor growth as verified through in vivo experimentation. Conclusions: The research herein demonstrates that CRC metastasis and cell proliferation are promoted by exosomal TFF3 via the upregulation of LINC00941. These outcomes offer newer understanding of exosomal TFF3 function in CRC pathogenesis and may inform future therapeutic strategies.

Exosomal; TFF3; Colorectal cancer; LINC00941

[1] Klimeck L, Heisser T, Hoffmeister M, Brenner H. Colorectal cancer: a health and economic problem. Best Practice & Research Clinical Gastroenterology. 2023; 66: 101839.

[2] Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer and Metastasis Reviews. 2024; 43: 729–753.

[3] Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends in Pharmacological Sciences. 2023; 44: 222–236.

[4] Zhao W, Jin L, Chen P, Li D, Gao W, Dong G. Colorectal cancer immunotherapy—recent progress and future directions. Cancer Letters. 2022; 545: 215816.

[5] Al Zein M, Boukhdoud M, Shammaa H, Mouslem H, El Ayoubi LM, Iratni R, et al. Immunotherapy and immunoevasion of colorectal cancer. Drug Discovery Today. 2023; 28: 103669.

[6] Shin S, Ko H, Kim CH, Yoon BK, Son S, Lee JA, et al. Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy. Nature Materials. 2023; 22: 656–665.

[7] Rossi HL, Ortiz-Carpena JF, Tucker D, Vaughan AE, Mangalmurti NS, Cohen NA, et al. Trefoil factor family: a troika for lung repair and regeneration. American Journal of Respiratory Cell and Molecular Biology. 2022; 66: 252–259.

[8] May FEB, Westley BR. TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer. Endocrine-Related Cancer. 2015; 22: 465–479.

[9] Guleng B, Han J, Yang J, Huang Q, Huang J, Yang X, et al. TFF3 mediated induction of VEGF via hypoxia in human gastric cancer SGC-7901 cells. Molecular Biology Reports. 2012; 39: 4127–4134.

[10] Yuan Z, Chen D, Chen X, Yang H, Wei Y. Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells. Cancer Cell International. 2017; 17: 7.

[11] Wang X, Qin H. TFF3 promotes pituitary tumor cell migration and angiogenesis via VEGFA. Acta Neurobiologiae Experimentalis. 2022; 82: 237–243.

[12] Yang T, Fu X, Tian R, Cui H, Li L, Han J, et al. TFF3 promotes clonogenic survival of colorectal cancer cells through upregulation of EP4 via activation of STAT3. Translational Cancer Research. 2023; 12: 1503–1515.

[13] Yusufu A, Shayimu P, Tuerdi R, Fang C, Wang F, Wang H. TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process. International Journal of Oncology. 2019; 55: 789–804.

[14] Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer. 2019; 1871: 455–468.

[15] Kok VC, Yu CC. Cancer-derived exosomes: their role in cancer biology and biomarker development. International Journal of Nanomedicine. 2020; 15: 8019–8036.

[16] Hu Y, Jiang Q, Zhai X, Liu L, Hong Y. Screening and validation of the optimal panel of reference genes in colonic epithelium and relative cancer cell lines. Scientific Reports. 2023; 13: 17777.

[17] Dong H, Liu Q, Chen C, Lu T, Xu K. LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis. Immunobiology. 2022; 227: 152176.

[18] Yu H, Feng H, Zeng H, Wu Y, Zhang Q, Yu J, et al. Exosomes: the emerging mechanisms and potential clinical applications in dermatology. International Journal of Biological Sciences. 2024; 20: 1778–1795.

[19] Ghosh S, Rajendran RL, Mahajan AA, Chowdhury A, Bera A, Guha S, et al. Harnessing exosomes as cancer biomarkers in clinical oncology. Cancer Cell International. 2024; 24: 278.

[20] Wu R, Zhang Y, Xu X, You Q, Yu C, Wang W, et al. Exosomal B7-H3 facilitates colorectal cancer angiogenesis and metastasis through AKT1/mTOR/VEGFA pathway. Cellular Signalling. 2023; 109: 110737.

[21] Zhao S, Mi Y, Guan B, Zheng B, Wei P, Gu Y, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. Journal of Hematology & Oncology. 2020; 13: 156.

[22] Jiang K, Chen H, Fang Y, Chen L, Zhong C, Bu T, et al. Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness. Journal of Experimental & Clinical Cancer Research. 2021; 40: 21.

[23] Xie Z, Xia J, Jiao M, Zhao P, Wang Z, Lin S, et al. Exosomal lncRNA HOTAIR induces PDL1+ B cells to impede anti-tumor immunity in colorectal cancer. Biochemical and Biophysical Research Communications. 2023; 644: 112–121.

[24] Wang J, He Z, Liu X, Xu J, Jiang X, Quan G, et al. LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2. Cell Death & Disease. 2022; 13: 718.

[25] Chang L, Zhou D, Luo S. Novel lncRNA LINC00941 promotes proliferation and invasion of colon cancer through activation of MYC. OncoTargets and Therapy. 2021; 14: 1173–1186.

[26] Ren MH, Chen S, Wang LG, Rui WX, Li P. LINC00941 promotes progression of non-small cell lung cancer by sponging miR-877-3p to regulate VEGFA expression. Frontiers in Oncology. 2021; 11: 650037.

[27] Liu H, Wu N, Zhang Z, Zhong X, Zhang H, Guo H, et al. Long non-coding RNA LINC00941 as a potential biomarker promotes the proliferation and metastasis of gastric cancer. Frontiers in Genetics. 2019; 10: 5.

[28] Wu N, Jiang M, Liu H, Chu Y, Wang D, Cao J, et al. LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway. Cell Death & Differentiation. 2021; 28: 219–232.